Over 40,000 EpiVacCorona vaccine doses enter civilian circulation
More than 40,000 doses of the EpiVacCorona COVID-19 vaccine have entered civilian circulation, Acting Deputy Director General of the Vector State Research Center for Virology and Biotechnology Tatiana Nepomnyashchikh told Russia’s Channel One television on Thursday. To date, slightly over 40,000 doses [of the EpiVacCorona vaccine] have entered civilian circulation. They have been delivered to a large number of Russian regions, she said.
Nepomnyashchikh added that the research center planned to manufacture from 100,000 to 150,000 vaccine doses per month. According to the official, about 1 million vaccine doses will be produced by its industrial partners. We have a clear-cut plan for scaling up production, which will enable us to manufacture about 400,000 [vaccine] doses in February and reach the overall production of 1 million doses by the end of March and make more than 4 million doses per month by the end of
National workers to get double support for three months: PAM - ARAB TIMES
arabtimesonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from arabtimesonline.com Daily Mail and Mail on Sunday newspapers.
Over 40,000 EpiVacCorona vaccine doses enter civilian circulation
tass.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tass.com Daily Mail and Mail on Sunday newspapers.
Funding boost to enhance Māori mental health outcomes
livenews.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from livenews.co.nz Daily Mail and Mail on Sunday newspapers.